tm logo
DICERNA PHARMACEUTICALS
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 31 Jan 2022

Last Applicant/ Owned by

75 Hayden Avenue

Lexington

MA

02421

Serial Number

87924207 filed on 16th May 2018

Registration Number

N/A

Correspondent Address

Bridget H. Labutta

Panitch Schwarze Belisario & Nadel LLP

Two Commerce Square

2001 Market Street, Suite 2800

Philadelphia PA 19103

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"PHARMACEUTICALS"

DICERNA PHARMACEUTICALS

The mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix. Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorderRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies

Class [042]
Computer & Software Services & Scientific Services


Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Mark Details


Serial Number

No 87924207

Mark Type

No Service Mark

Attorney Docket Number

No 689746.0058

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

24.15.04 -

Arrowheads

26.01.29 -

Helixes

26.05.21 -

Triangles that are completely or partially shaded

Description of Design Search

The mark consists of a vertical double helix positioned to the left of the words "DICERNA PHARMACEUTICALS". The word "DICERNA" is stacked directly above the word "PHARMACEUTICALS". A left pointing arrow head is positioned at the base of the letter "D" of "DICERNA", splicing the double helix.

Legal History


Show more

Status DateAction Taken
25th May 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
25th May 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25th May 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02th Feb 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
02th Feb 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02th Feb 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31st Jan 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
31st Jan 2022ABANDONMENT - NO USE STATEMENT FILED
13th Jan 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
13th Jan 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED